Market Cap

Imugene Limited Market Capitalization:

A$396.5 Million

AUD as of July 1, 2024

US$264.1 Million

business Imugene Limited Company Profile

Imugene Limited Main Stock Listing

ASX: IMU

Market Capitalization History of Imugene Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Imugene Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$860.3 M -16.27%
Jan. 1, 2023 A$1.03 B -46.77%
Jan. 1, 2022 A$1.93 B 210.00%
Jan. 31, 2021 A$622.7 M 0.00%
Jan. 1, 2021 A$622.7 M 334.78%
Jan. 31, 2020 A$143.2 M -30.30%
Jan. 1, 2020 A$205.5 M 65.00%
Jan. 31, 2019 A$124.5 M 11.11%
Jan. 1, 2019 A$112.1 M -24.50%
Jan. 31, 2018 A$148.5 M 60.00%
Jan. 1, 2018 A$92.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Imugene Limited Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Imugene Limited has the following listings and related stock indices.


Stock: ASX: IMU

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.